<< Read Full Article
<< Read Full Article
AstraZeneca Could Face Generic Prilosec Soon
AstraZeneca (AZN Quote)could soon face generic competition against its super blockbuster Prilosec after a U.S. District Court decision Friday.
Patent protection for the drug ended in October, but the drugmaker has filed suits against generic makers over patents covering the way the ulcer drug's capsules are manufactured.
Judge Barbara Jones of the U.S. Court for the Southern District of New York ruled for AstraZeneca and against all but one of the generic firms, Kremer's Urban Development Co., a U.S. subsidiary of German drugmaker Schwarz Pharma. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.58 | 1,108.86 | 2,175.81 | 32.75 |
Oil *
79.69
|
|
UP
126.74
|
UP
13.23
|
UP
31.21
|
UP
0.74
|
10 Yr
3.28%
SPDR Gold
117.38
|
|
+1.23%
|
+1.21%
|
+1.46%
|
+2.31%
|
Data delayed 20 minutes |
Connect with TheStreet